Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

LIVERMORE FALLS, Maine (WABI) - A Colorado man wanted for sexual exploitation of a child was arrested in Maine on Friday. The ...

Assam's Health Minister, Ashok Singhal, urged government doctors to prescribe hospital pharmacy and generic medicines to ...

DOVER-FOXCROFT, Maine (WABI) - A crash in Dover-Foxcroft early Sunday morning left one person dead and another seriously ...

The race for the Super Bowl continues on with the divisional round. What started as a field of 14 is about to be down to just eight, as the results from wild-card weekend have knocked out six ...

WASHINGTON, Jan 16 - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' blockbuster heart-failure drug Entresto after a U.S. appeals ...

A U.S. appeals court has lifted a temporary halt it imposed on the launch of a generic version of Novartis's (NYSE:NVS) top-selling cardiac drug Entresto. The U.S. Court of Appeals for the ...

But they have now been sentenced to decades behind bars after they were unmasked as the account holders "Air Ear" and "Generic Bull". One of the brothers was arrested on the continent, with cash ...

The launch of a generic version of Novartis's (NYSE:NVS) blockbuster cardiac drug Entresto has reportedly been temporarily blocked by a federal appeals court as it considers the drugmaker's ...

Hello and welcome to India TV Digital's coverage of all the breaking news coming across from India and the world. Stay home, stay safe, and stay informed as our team of dedicated editors/reporters ...

A Washington DC federal judge on Wednesday refused Novartis' NOVN.S eleventh-hour bid to block drugmaker MSN Pharmaceuticals from launching a generic version of Novartis' blockbuster heart-failure ...

WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis (SIX:NOVN)' blockbuster heart-failure drug Entresto late on Wednesday.